Introduction and Overview — Addressing Current Challenges in Thrombosis Medicine for the CV Specialist
Samuel Z. Goldhaber, MD

The Emerging Role of Direct Thrombin and Factor Xa Inhibition in Cardiovascular Medicine: Mechanisms and Applications for Thrombosis Mitigation Across the CV Disease Spectrum
Jeffrey L. Weitz, MD, FRCP, FACP

Challenges and Emerging Dimensions of Stroke Prevention in the Setting of Atrial Fibrillation (AF): Achieving Balance Between Thromboprophylaxis and Bleeding Reduction
Jonathan L. Halperin, MD

Stroke Prevention in High Risk Populations: From Warfarin to New Options and Strategies
Elaine M. Hylek, MD, MPH

Anticoagulation for Stroke Prevention in Atrial Fibrillation
Samuel Z. Goldhaber, MD

Question and Answer Interactive Session
Faculty Panel